Clinical

Dataset Information

0

Effect of probiotics on colorectal cancer in clinical trials


ABSTRACT: Interventions: Ten subjects receive probiotic product contained 10 million CFU in viable form 3 times a day for 6 months,Ten subjects receive probiotic product contained 10 million CFU in non viable form 3 times a day for 6 months, Ten subjects receive product without probiotic 3 times a day for 6 months;Active Comparator Dietary Supplement,Active Comparator Dietary Supplement,Placebo Comparator Dietary Supplement;probiotic products in viable form,probiotic products in non viable form,Control Primary outcome(s): reduceing of number of pathogens in gut at 6 months after intervention number of pathogens / Anova Study Design: Randomized

DISEASE(S): Probiotics, Colorectal Cancer, Butyrate, Anti-inflammation, Stimulating Immune,Colorectal Cancer Is The Third Most Prevalent Cause Of Death Among The Different Types Of Cancer Worldwide- Imbalance Of Microorganisms In Gut Causes Colorectal Cancer- Probiotic Strains Can Help To Balance Of Microorganisms In Gut

PROVIDER: 2727906 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2734058 | ecrin-mdr-crc
2021-04-08 | MTBLS1168 | MetaboLights
| 72928 | ecrin-mdr-crc
| 2485704 | ecrin-mdr-crc
| PRJNA603575 | ENA
2012-11-20 | E-GEOD-40638 | biostudies-arrayexpress
2014-01-31 | E-MEXP-3031 | biostudies-arrayexpress
| 2567146 | ecrin-mdr-crc
2015-01-21 | GSE65152 | GEO
2019-09-10 | GSE123805 | GEO